Life Sciences
Asia-Pacific Guide 2025 : Japan
Band 1
Email address
[email protected]Contact number
+81 3 6889 7000About
Provided by Nagashima Ohno & Tsunematsu
With expertise in, and knowledge of, Japanese pharmaceutical, medical device, food, medical, research and other various life sciences related regulations, we provide high-quality legal services to international and domestic pharmaceutical companies and medical device manufacturers, medical data and digital health businesses, drug wholesalers and retailers, medical and pharmaceutical service providers, food and beverages companies, as well as laboratories, research institutions, and other businesses related to the health and lives of people and other living things in the broad life sciences sector, including regenerative medicine products.
Based on our specialized knowledge and knowhow of the relevant regulations, we advise on and assist with a wide variety of regulatory matters, including regulatory interpretation and compliance issues, communication and interaction with Japanese regulatory authorities, clinical trials and clinical research, drug examinations, licenses and permits, NHI price listings, advertisements and promotional activities, as well as recalls, regulatory inspections, crisis management and internal investigations for potential misconduct or violations.
For more details, please visit our website:
https://www.noandt.com/en/practices/pharmaceutical_and_healthcare/
Chambers Review
Nagashima Ohno & Tsunematsu excels in advising key domestic and international pharmaceutical, healthcare and medical device companies on corporate transactions, including acquisitions and business integrations, alongside merger controls. The firm is skilled in advising on areas such as regulatory regimes and patent protection, together with licensing and distribution agreements. Its clients additionally benefit from the firm's practice in related areas such as corporate, finance and IP, and the team is well placed to provide advice to major life sciences corporations in relation to crisis management.
Work Highlights
- Nagashima Ohno & Tsunematsu represented Pfizer Japan in lawsuits regarding deaths and other harmful effects allegedly caused by its Comirnaty COVID-19 vaccine.
Strengths
Provided by Chambers
"The firm's response is quick and accurate. They manage a large number of tasks accurately and also manage and follow up with clients very well."
"Nagashima Ohno accurately grasped our issues and proposed a solution with the minimum amount of time and cost for us."
"The firm's response is quick and accurate. They manage a large number of tasks accurately and also manage and follow up with clients very well."
"Nagashima Ohno accurately grasped our issues and proposed a solution with the minimum amount of time and cost for us."
Notable Practitioners
Kenji Utsumi is a legendary figure in the team and also in the wider life sciences industry. He advises leading Japanese and foreign pharmaceutical companies on a full range of business integration, regulatory and litigation work.
"He always grasps business ideas well and accurately points out legal risks regarding regulations in the pharmaceutical industry."
"Kenji Utsumi has a good understanding of our business and a deep knowledge of the industrial field, so we trust him for a wide range of projects."
Kensuke Suzuki is one of the pillars of the firm's transactional and regulatory life sciences offering, and he is highly regarded in the market.
"We believe that the breadth and depth of his knowledge in the medical industry is the best in Japan. His soft demeanour also matches the character of the industry."
"Kensuke Suzuki is a leader in the medical products industry and has a strong commercial awareness."